Ascidian Therapeutics

Ascidian Therapeutics is a biotechnology company dedicated to developing innovative exon-editing RNA therapeutics that target the root causes of diseases. Inspired by the natural RNA splicing mechanisms of sea squirts, Ascidian has created a first-of-its-kind platform capable of precisely rewriting RNA sequences to restore normal protein function. By replacing mutated exons, Ascidian's technology offers a powerful and versatile approach to treating diseases that are currently out of reach of traditional gene editing and gene therapy methods.

Ascidian's lead program focuses on ABCA4 retinopathy, including Stargardt disease, a common form of inherited macular degeneration. Their approach holds promise for a one-time treatment that could halt or reverse the vision loss associated with this debilitating condition. Ascidian is also actively developing a broad pipeline of exon editing therapies targeting various retinal, neurological, neuromuscular, and other genetic diseases. The company's commitment to scientific excellence and its innovative approach have earned Ascidian recognition as a "Fierce 15" Biotech Company of 2024, highlighting its potential to revolutionize the treatment of complex genetic disorders.

Ascidian Therapeutics does not mention work flexibility on their website or in their job postings.

Ascidian Therapeutics is a biotechnology company dedicated to redefining the treatment of disease by rewriting RNA. They are developing a novel RNA exon editing platform that targets the underlying causes of disease by editing and replacing human exons. Their mission is to create a new class of medicines that address diseases currently out of reach of gene editing technologies or RNA therapeutic approaches, ultimately delivering life-changing treatments for patients.

Ascidian Therapeutics emphasizes a collaborative and inclusive work environment that fosters diversity, inclusion, and belonging. They believe that creativity thrives in an environment that welcomes diverse thoughts, experiences from various industries and disciplines, and different cultural backgrounds.

Ascidian Therapeutics is committed to fostering a culture of excellence that embraces diversity, inclusion, and belonging. They believe that creativity flourishes in an environment where a variety of thoughts, approaches, and experiences are welcomed. This includes diverse perspectives across industries and disciplines, as well as cultural backgrounds.